HomePVLA • NASDAQ
add
Palvella Therapeutics Inc
Previous close
$124.65
Day range
$116.40 - $131.61
Year range
$18.23 - $151.18
Market cap
1.53B USD
Avg Volume
377.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.30M | 158.91% |
Net income | -12.71M | -221.79% |
Net profit margin | — | — |
Earnings per share | -1.08 | 79.89% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 57.98M | -30.65% |
Total assets | 59.56M | -32.50% |
Total liabilities | 31.58M | 23.21% |
Total equity | 27.98M | — |
Shares outstanding | 14.31M | — |
Price to book | 55.15 | — |
Return on assets | -44.68% | — |
Return on capital | -55.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -12.71M | -221.79% |
Cash from operations | -4.93M | 8.66% |
Cash from investing | — | — |
Cash from financing | -49.00K | -100.07% |
Net change in cash | -5.58M | -108.05% |
Free cash flow | -9.27M | -566.83% |
About
Website
Employees
14
